Similar articles

• [Comparative study on rifomycin in resumption of treatment of pulmonary tuberculosis cases with polyresistant bacilli].

  Prignot J, Gyselen A, Cosemans J, De Brabandere R, Verbist L, Simon-Pouthier F. Prignot J, et al. Acta Tuberc Pneumol Belg. 1969;60(3):487-95. Acta Tuberc Pneumol Belg. 1969. PMID: 4906102 Clinical Trial. French. No abstract available.
• [3 cases of treatment of advanced tuberculosis with multiresistant bacilli by combined rifomycin-ethambutol].

  Hennebert A. Hennebert A. Acta Tuberc Pneumol Belg. 1969;60(3):507-12. Acta Tuberc Pneumol Belg. 1969. PMID: 5371675 French. No abstract available.
• Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.

  Engbaek HC, Vergmann B. Engbaek HC, et al. Scand J Respir Dis. 1970;51(1):11-27. Scand J Respir Dis. 1970. PMID: 5456856 No abstract available.
• [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].

  Freerksen E. Freerksen E. Dtsch Med Wochenschr. 1970 Jan 16;95(3):139-41. Dtsch Med Wochenschr. 1970. PMID: 5411222 German. No abstract available.
• [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].

  Sakurai H, Watanabe Y, Yamanaka M, Moriguchi T, Fujii K, Uenoyama T. Sakurai H, et al. Kekkaku. 1980 Nov;55(11):485-91. Kekkaku. 1980. PMID: 6780716 Japanese. No abstract available.